Streetbeat News

Partnerships

VCIG

VCI Global has announced a strategic collaboration with Evolve Capital Advisory Private Limited to provide companies with opportunities for capital market access through public listings on NASDAQ or SGX.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 1:04 pm

MIRA

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) has announced promising results from AI simulations for MIRA1a, a potential treatment for anxiety, appetite, and cognition issues. The simulations, conducted with InSilicoTrials, suggest MIRA1a's advantages over THC, including fewer side effects. MIRA1a targets specific brain receptors and may offer superior anti-anxiety effects, appetite suppression, and cognitive enhancement. The company is working towards an IND Application with the FDA, positioning MIRA1a as a significant development in neuropharmacology.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 1:03 pm

LUNR

Intuitive Machines, Inc. has successfully delivered its IM-1 mission Nova-C lunar lander to Cape Canaveral, Florida. The launch, in coordination with SpaceX, is targeted for no earlier than January 12, 2024. The mission is part of NASA's CLPS initiative, aiming to establish a sustainable human presence on the Moon. The lander was completed in September and will be operated from Houston, Texas, with a journey of approximately six-and-a-half days to the Moon.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 1:03 pm

AAPL

EA

META

NVDA

Insiders at Apple, Meta Platforms, NVIDIA, and Electronic Arts have recently sold shares of their respective companies. Apple's Principal Accounting Officer sold shares amid news of ending a credit card partnership with Goldman Sachs. Meta's COO sold shares as the company faces a new complaint with the Austrian data protection authority. NVIDIA's EVP of Operations sold shares while the CEO discussed U.S. chip manufacturing dependency. EA's CFO sold shares following an earnings report that beat estimates.

Portfolio Pulse from Lisa Levin

December 04, 2023 | 1:00 pm

GNRC

WBX

Generac has made a minority investment in Wallbox, which includes a board seat and a global commercial agreement to supply energy management systems to Generac's customers. The financial terms of the investment were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 12:36 pm

ABSI

AZN

Absci Corporation has entered into a collaboration with AstraZeneca to advance an AI-driven oncology candidate. The financial terms of the agreement were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 12:34 pm

NFLX

VZ

Verizon is planning to offer a streaming bundle that includes Netflix and HBO Max as a $10 per month perk for its myPlan customers. This move is aimed at enhancing the value proposition for Verizon's services and could potentially attract more subscribers to its myPlan offerings.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 12:32 pm

PINC

TRVN

Trevena has secured a national group purchasing agreement for its product Olinvyk with Premier, starting December 1, 2023. This agreement enables Premier members to benefit from special pricing and terms for Olinvyk that have been pre-negotiated by Premier.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 12:14 pm

TD

TD Bank Group has announced a major expansion of its Global Financial Institutions investment banking coverage in the US, along with growth in other product areas. This strategic move aims to enhance the bank's services and market presence in the United States.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 12:14 pm

ABSI

AZN

NVDA

RHHBY

AstraZeneca plc (NASDAQ:AZN) has entered into a partnership with Absci Corporation (NASDAQ:ABSI) to develop an AI-driven antibody for cancer treatment, with a deal value of up to $247 million. Absci will receive an upfront fee, R&D funding, milestone payments, and royalties on product sales. The collaboration aims to leverage Absci's AI technology for protein analysis to accelerate drug discovery. This move is part of a broader trend of incorporating AI into pharmaceutical research, as seen with Genentech's recent partnership with NVIDIA Corporation (NASDAQ:NVDA). ABSI stock rose 8.62% in premarket trading.

Portfolio Pulse from Vandana Singh

December 04, 2023 | 11:58 am